ALKERAN

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United States, South Africa

Active ingredients

The drug ALKERAN contains one active pharmaceutical ingredient (API):

1 Melphalan UNII Q41OR9510P - MELPHALAN

Melphalan is a bifunctional alkylating agent. Formation of carbonium intermediates from each of the two bis-2-chloroethyl groups enables alkylation through covalent binding with the 7-nitrogen of guanine on DNA, cross-linking the two DNA strands and thereby preventing cell replication. Read about Melphalan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ALKERAN	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01AA03	Melphalan	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2547C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 505617060041517, 505617060041617
Country: CA	Health Products and Food Branch	Identifier(s): 00004715, 02087286
Country: EE	Ravimiamet	Identifier(s): 1004410, 1006434, 1708770
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 125125
Country: FR	Base de données publique des médicaments	Identifier(s): 68262525, 68708664
Country: HK	Department of Health Drug Office	Identifier(s): 03792, 37994
Country: IE	Health Products Regulatory Authority	Identifier(s): 11193
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1069
Country: JP	医薬品医療機器総合機構	Identifier(s): 4219002F1034, 4219403F1023
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000049, 1006932
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 62511
Country: NL	Z-Index G-Standaard	Identifier(s): 13669249
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 35254, 65641
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10081, 309
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100003930, 100344736
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W58865001, W58865002
Country: SG	Health Sciences Authority	Identifier(s): 11822P, 11873P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699874080021
Country: US	FDA, National Drug Code	Identifier(s): 52609-0001
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/26/0506, 27/34/0507, H/26/2744